Literature DB >> 18514418

Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells.

Shaik Shavali1, Holly M Brown-Borg, Manuchair Ebadi, James Porter.   

Abstract

Alpha-synuclein (alpha-syn) is implicated in the pathogenesis of Parkinson's disease (PD). Mutations in alpha-syn gene or alpha-syn locus (SNCA) triplication are associated with mitochondrial abnormalities and early onset of familial PD. The goals of the present study were to examine whether alpha-syn is localized in the mitochondria of alpha-syn overexpressing cells (HEK-syn cells); and whether alpha-syn overexpression causes cells to be more vulnerable to mitochondrial toxin, rotenone. Western blotting and confocal microscopy techniques were employed to assess localization of alpha-syn in the mitochondria of HEK-293 cells that were stably transfected with human wild-type alpha-syn. The results demonstrated that the mitochondrial fractions that were isolated from HEK-syn cells showed the presence of alpha-syn, whereas, no alpha-syn was detected in the mitochondrial fractions of control HEK cells. The mitochondria of HEK-syn cells were found to be more susceptible to rotenone-induced toxicity when compared to control HEK cells. The intracellular ATP levels were significantly decreased in HEK-syn cells in response to sub toxic concentrations of rotenone. These results suggest that under overexpression conditions, alpha-syn may translocate to mitochondria and cause enhanced toxicity in response to sub toxic concentrations of mitochondrial toxins. This study has implications to the pathogenesis of familial PD where alpha-syn overexpression is mainly involved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514418      PMCID: PMC2502066          DOI: 10.1016/j.neulet.2008.05.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; J B Clark; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

3.  Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Authors:  P A Trimmer; R H Swerdlow; J K Parks; P Keeney; J P Bennett; S W Miller; R E Davis; W D Parker
Journal:  Exp Neurol       Date:  2000-03       Impact factor: 5.330

4.  alpha-Synuclein affects the MAPK pathway and accelerates cell death.

Authors:  A Iwata; M Maruyama; I Kanazawa; N Nukina
Journal:  J Biol Chem       Date:  2001-09-17       Impact factor: 5.157

5.  Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Authors:  William Dauer; Nikolai Kholodilov; Miquel Vila; Anne-Cecile Trillat; Rose Goodchild; Kristin E Larsen; Roland Staal; Kim Tieu; Yvonne Schmitz; Chao Annie Yuan; Marcelo Rocha; Vernice Jackson-Lewis; Steven Hersch; David Sulzer; Serge Przedborski; Robert Burke; Rene Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

6.  Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Neurosci Lett       Date:  2002-03-08       Impact factor: 3.046

7.  1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.

Authors:  Shaik Shavali; Edward C Carlson; John C Swinscoe; Manuchair Ebadi
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

8.  Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

Authors:  D W Miller; S M Hague; J Clarimon; M Baptista; K Gwinn-Hardy; M R Cookson; A B Singleton
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

9.  Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

Authors:  David D Song; Clifford W Shults; Abbyann Sisk; Edward Rockenstein; Eliezer Masliah
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

10.  Mitochondrial association of alpha-synuclein causes oxidative stress.

Authors:  M S Parihar; A Parihar; M Fujita; M Hashimoto; P Ghafourifar
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

View more
  71 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

3.  The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.

Authors:  Erin K Butler; Aaron Voigt; A Kathrin Lutz; Jane P Toegel; Ellen Gerhardt; Peter Karsten; Björn Falkenburger; Andrea Reinartz; Konstanze F Winklhofer; Jörg B Schulz
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

Review 4.  Impact of membrane curvature on amyloid aggregation.

Authors:  Mayu S Terakawa; Yuxi Lin; Misaki Kinoshita; Shingo Kanemura; Dai Itoh; Toshihiko Sugiki; Masaki Okumura; Ayyalusamy Ramamoorthy; Young-Ho Lee
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-28       Impact factor: 3.747

5.  Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells.

Authors:  N Plotegher; E Gratton; L Bubacco
Journal:  Biochim Biophys Acta       Date:  2014-02-20

6.  Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein.

Authors:  Ken Nakamura; Venu M Nemani; Farnaz Azarbal; Gaia Skibinski; Jon M Levy; Kiyoshi Egami; Larissa Munishkina; Jue Zhang; Brooke Gardner; Junko Wakabayashi; Hiromi Sesaki; Yifan Cheng; Steven Finkbeiner; Robert L Nussbaum; Eliezer Masliah; Robert H Edwards
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

Review 7.  A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease.

Authors:  Charleen T Chu
Journal:  Hum Mol Genet       Date:  2010-04-12       Impact factor: 6.150

8.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 9.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

Review 10.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.